Need professional-grade analysis? Visit stockanalysis.com
$9.24B
34.90
733
N/A
Price Chart
Risk-Adjusted Performance
Apotea (APOTEA) Price Performance
Apotea (APOTEA) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at SEK57.89, up 1.51% from the previous close.
Over the past year, APOTEA has traded between a low of SEK55.58 and a high of SEK121.14. The stock has lost 22.2% over this period. It is currently 52.2% below its 52-week high.
Apotea has a market capitalization of $9.24B, with a price-to-earnings ratio of 34.90.
About Apotea
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, charity, and eyes and ears. In addition, the company offers services comprising leasing, leasing of personnel to related companies. and market contributions. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Company Info
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Exchange
- Nasdaq Stockholm
- Currency
- SEK
- Country
- Sweden
Financial Metrics
- Revenue (TTM)
- $7.09B
- EBITDA
- $406.70M
- Profit Margin
- 3.71%
- EPS (TTM)
- 2.52
- Book Value
- 7.95
Technical Indicators
- 52 Week High
- SEK 122.00
- 52 Week Low
- SEK 55.08
- 50 Day MA
- SEK 90.42
- 200 Day MA
- SEK 90.21
- Beta
- N/A
Valuation
- Trailing P/E
- 34.90
- Forward P/E
- N/A
- Price/Sales
- 0.80
- Price/Book
- 6.85
- Enterprise Value
- $6.08B